UBS Group
HPTX

UBS Group’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

UBS Group’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-315
Closed -$15K – 9271
2015
Q1 		$15K Sell
315
-648
-67% -$19.4K ﹤0.01% 7324
2014
Q4 		$23K Buy
+963
New +$21.7K ﹤0.01% 7494

UBS Group's HPTX Position: Q2 2015 in Review

UBS Group sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 315 shares — an estimated $15K sold.

UBS Group first reported a position in HPTX in Q4 2014 and held it in 2 quarters. The position peaked at $23K in Q4 2014. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • UBS Group reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • UBS Group sold 315 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $15K.
  • UBS Group first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q4 2014 and held it in 2 quarters.
  • UBS Group's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $23K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on UBS Group's 13F filing for Q2 2015, filed 14 Aug 2015.